Cited by 11Liver physiology and pathologyDrug-Induced Hepatotoxicity and ProtectionLiver Disease Diagnosis and Treatment

Lactucin alleviates liver fibrosis by regulating the TLR4-MyD88-MAPK/NF-κB signaling pathway through intestinal flora

Zhu, Liping, Lv, Bo, Gao, Yuefeng, Qin, Dongmei·2025·Archives of Biochemistry and Biophysics

Abstract

Ethnopharmacological relevance Cichorium glandulosum (CG) is a kind of traditional Chinese medicine, mainly produced in Xinjiang and Inner Mongolia, and its medicinal part is mainly the dried root of CG. CG is a commonly used medicine in Uygur medicine, which has good pharmacological effects. Lactucin (LC) in this study is the main sesquiterpene monomer compound obtained from the ethyl acetate extract of CG. The purity of LC obtained by our research group in the previous stage reached 98.1 %, which met the purity requirements of chemical control of traditional Chinese medicine. At present, the research on the pharmacological action of CG mainly focuses on the extract of CG, and there is little research on the monomer compounds and exact pharmacological action mechanism in CG. Aim of the study The aim of this study is to investigate the mechanism of lactucin (LC) in alleviating liver fibrosis by regulating TLR4-related inflammatory pathway through intestinal flora-intestine-liver axis. Materials and methods Firstly, the content of LC was determined by HPLC. In vitro, hepatic fibrosis cell model was induced and cytotoxicity was detected by MTT assay. QRT-PCR and Western Blot were used to detect the effect of LC on the expression of proteins related to TLR4-MyD88-MAPK/NF-κB signaling pathway. In vivo, carbon tetrachloride and dextran sodium sulfate were used to induce liver fibrosis and enteritis in rats. Detection of liver fibrosis index, H&E staining, Sirius red staining, immunofluorescence and Western Blot were used to detect the degree and action pathway of liver fibrosis. 16S rRNA analysis and bile acid targeted metabolism were used to explore the role of intestinal flora in liver fibrosis. Results In vitro, LC can significantly inhibit the mRNA levels of TLR4 and related inflammatory factors, inhibit the expression of TLR4-MyD88-MAPK/NF-κB pathway protein, and reduce the level of intracellular reactive oxygen species, with the same effect as TLR4 inhibitors. In vivo, experimental results show that LC can reduce the degree of liver fibrosis and colitis, significantly reduce the levels of MDA and MPO in colon tissue, increase the level of SOD, reduce the activities of HYP, AKP, AST, ALT, TBA and γ-GT in serum, and increase the level of Alb. LC can also inhibit the expression of TLR4-MyD88-MAPK/NF-κB pathway, and inhibit the expression of TLR4 protein in liver and increase the expression of ZO-1 protein in colon. In addition, LC can regulate the flora composition of liver fibrosis and improve bile acid metabolism. Conclusion This study found that LC can alleviate liver fibrosis, and suggested that the beneficial effect of LC on liver fibrosis may be achieved by regulating TLR4-MyD88-MAPK pathway and improving intestinal flora through intestinal liver axis. At the same time, it is revealed that LC is the main component of CG for treating liver fibrosis, which lays a theoretical foundation for the research and development of new drugs and clinical research of CG in the later period.

Integrity signals

Registry

Crossref · 10.1016/j.abb.2025.110341

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In human macrophages, reduced SUMOylation activates KLF4, which induces SOCS1 and inhibits JAK-STAT and TLR4-MyD88 signaling, thereby reducing NF-κB and MAP kinase activity and promoting restorative polarization.

    “In human macrophages, reduced SUMOylation activates KLF4, which induces suppressor of cytokine signaling 1 (SOCS1) and inhibits JAK–STAT and TLR4–MyD88 signaling, thereby reducing NF-κB and MAP kinase activity and promoting restorative polarization (81–85).”

Cites

Flagged first, then by citations

1 of the 37 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Zhu, L., Lv, B., Gao, Y., & Qin, D.
Affiliations
  • Shihezi University (CN)
  • Henan University of Science and Technology (CN)
Corresponding author
Qin, Dongmei
Venue
Archives of Biochemistry and Biophysics
Publisher
Elsevier BV
Published
2025-04
Volume
766
Pages
110341
ISSN
0003-9861 (ISSN-L)
OpenAlex
W4407392850
Cited by
11
References
37
Citations by year
2026: 5 · 2025: 6
FWCI
6.10
Type
journal article
Language
en
Open access
closed
Locations
  • Archives of Biochemistry and Biophysics (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Xinjiang Production and Construction Corps
  • National Natural Science Foundation of China
Topics
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
  • Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
Keywords
lactucin, liver fibrosis, gut microbiota, gut-liver axis, intestinal inflammation, sesquiterpenes, bile acid metabolism, reactive oxygen species, colitis, carbon tetrachloride-induced fibrosis
MeSH terms
Gastrointestinal Microbiome, Animals, Humans, Liver Cirrhosis, Male, Sesquiterpenes, Signal Transduction, NF-kappa B, Rats, Sprague-Dawley, MAP Kinase Signaling System, Toll-Like Receptor 4, Rats, Myeloid Differentiation Factor 88

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review